¹û¶³´«Ã½

¹û¶³´«Ã½ Farm: Is a Big Tech healthcare revolution on its way?

This week, Microsoft announced a $20bn deal to acquire a healthcare AI specialist

Playing the retail revival

Michael Taylor is keeping an eye on a retailer that could see a share price revival as high streets open again

Don’t dismiss upside at DMGT

There is value in being one of the nation’s favourite publishers

Clean up with Rentokil

The pest control and hygiene specialist is tapping into long-term growth trends and international expansion opportunities

¹û¶³´«Ã½ Farm: Half truths about the value revival

A popular explanation for value investors’ 14 years of pain and recent revival of fortunes is only half right, according to a recent paper from GMO. This could have implications for the value bounce back

Is Mirriad setting a new trend?

Michael Taylor explains why the stage may be set for a strong recovery in native advertising minnow Mirriad Advertising’s shares.

A stroke of Genus?

Rising demand for animal protein is fuelling usage of genetic breeding technologies

Workspace's rerating potential underappreciated

Shares in the flexible office provider could benefit from the gradual reopening of the economy and return to offices

¹û¶³´«Ã½ Farm: The Kraken wakes

It’s not only retail investors that do stupid things. And when the big boys and girls YOLO, there can be far wider reaching consequences for everyone

A change in fortune is not beyond the Realms

Michael Taylor explains how friends’ sentiments helped him unearth a bargain